Cleared Traditional

REVOLUTION RADIAL IMMUNODIFFUSION PLATE (K831811) - FDA 510(k) Clearance

Class I Immunology device.

K831811 · Calbiochem-Behring Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1983
Decision
52d
Days
Class 1
Risk

K831811 is an FDA 510(k) clearance for the REVOLUTION RADIAL IMMUNODIFFUSION PLATE. Classified as Plates And Equipment, Radial Immunodiffusion (product code JZQ), Class I - General Controls.

Submitted by Calbiochem-Behring Corp. (Mchenry, US). The FDA issued a Cleared decision on July 28, 1983 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.4800 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Calbiochem-Behring Corp. devices

Submission Details

510(k) Number K831811 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 1983
Decision Date July 28, 1983
Days to Decision 52 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 104d · This submission: 52d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JZQ Plates And Equipment, Radial Immunodiffusion
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.4800
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.